Association of the serum albumin level with prognosis in chronic kidney disease patients

[1] Foreman KJ(2020)Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017 Lancet 395 709-733

[2] Marquez N(2017)Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017 Lancet 392 1789-1858

[3] Dolgert A(2018)Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories Lancet 392 2052-2090

[4] Fukutaki K(2010)Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2073-2081

[5] Fullman N(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305

[6] McGaughey M(2010)Reassessment of albumin as a nutritional marker in kidney disease J Am Soc Nephrol 21 223-230

[7] Matsushita K(2013)Serum albumin levels: a simple answer to a complex problem? Are we on the right track of assessing metabolic syndrome? Endocrinol Metab (Seoul) 28 17-124

[8] van der Velde M(2009)Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study Nephrol Dial Transplant 25 119-1700

[9] Astor BC(2013)Predictors of end-stage renal disease in the urban poor J Health Care Poor Underserv 24 1686-92

[10] Woodward M(1997)Serum albumin, coronary heart disease risk, and mortality in an elderly cohort Epidemiology 8 87-2924

[1] Foreman KJ(2020)Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017 Lancet 395 709-733

[2] Marquez N(2017)Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017 Lancet 392 1789-1858

[3] Dolgert A(2018)Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories Lancet 392 2052-2090

[4] Fukutaki K(2010)Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2073-2081

[5] Fullman N(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305

[6] McGaughey M(2010)Reassessment of albumin as a nutritional marker in kidney disease J Am Soc Nephrol 21 223-230

[7] Matsushita K(2013)Serum albumin levels: a simple answer to a complex problem? Are we on the right track of assessing metabolic syndrome? Endocrinol Metab (Seoul) 28 17-124

[8] van der Velde M(2009)Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study Nephrol Dial Transplant 25 119-1700

[9] Astor BC(2013)Predictors of end-stage renal disease in the urban poor J Health Care Poor Underserv 24 1686-92

[10] Woodward M(1997)Serum albumin, coronary heart disease risk, and mortality in an elderly cohort Epidemiology 8 87-2924